{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:27Z","timestamp":1793442687123,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015939","name":"Hubei Provincial Key Laboratory of Bioinorganic Chemistry and Materia Medica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115384","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:21:06Z","timestamp":1790004066000},"page":"115384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Catalytical nanogels reprogram immunosuppressive metabolic networks for activatable cancer photo-immunotherapy"],"prefix":"10.1016","volume":"399","author":[{"given":"Mengting","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congqiang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxu","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2026.115384_bb0005","first-page":"7","article-title":"Cancer Statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115384_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"27","key":"10.1016\/j.jconrel.2026.115384_bb0015","doi-asserted-by":"crossref","first-page":"25134","DOI":"10.1021\/acsnano.5c05395","article-title":"Reprogramming immunodeficiency in lung metastases via PD-L1 siRNA delivery and antigen capture of nanosponge-mediated dendritic cell modulation","volume":"19","author":"Huynh","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115384_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113606","article-title":"Stimuli-responsive polymer-dasatinib prodrug to reprogram cancer-associated fibroblasts for boosted immunotherapy","volume":"381","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115384_bb0025","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1021\/acsnano.4c09525","article-title":"Reprogramming dysfunctional dendritic cells by a versatile catalytic dual oxide antigen-captured nanosponge for remotely enhancing lung metastasis immunotherapy","volume":"19","author":"Chiang","year":"2025","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115384_bb0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","article-title":"Exploiting bacteria for cancer immunotherapy","volume":"21","author":"Kwon","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115384_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40824-018-0133-y","article-title":"New opportunities for nanoparticles in cancer immunotherapy","volume":"22","author":"Park","year":"2018","journal-title":"Biomater. Res."},{"key":"10.1016\/j.jconrel.2026.115384_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115384_bb0045","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jconrel.2025.01.053","article-title":"Disrupting the dangerous alliance: dual anti-inflammatory and anticoagulant strategy targets platelet-neutrophil crosstalk in sepsis","volume":"379","author":"Chen","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115384_bb0050","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jconrel.2025.02.049","article-title":"Nanoparticles encapsulating antigenic peptides induce tolerogenic dendritic cells in situ for treating systemic lupus erythematosus","volume":"380","author":"Qin","year":"2025","journal-title":"J. Control. Release"},{"issue":"13","key":"10.1016\/j.jconrel.2026.115384_bb0055","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1039\/C9CS00773C","article-title":"Molecular and nanoengineering approaches towards activatable cancer immunotherapy","volume":"49","author":"Zhang","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"24","key":"10.1016\/j.jconrel.2026.115384_bb0060","article-title":"Dysfunctional T cell reprogramming via cascade-responsive catalytic nanosponges-mediated tumor-specific antigen capture for remote glioblastoma immunotherapy","volume":"36","author":"Huynh","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115384_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113604","article-title":"A nasally administrated reactive oxygen species-responsive carrier-free gene delivery nanosystem for Alzheimer's disease combination therapy","volume":"381","author":"Chen","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115384_bb0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jconrel.2023.03.015","article-title":"Modulating tumor-stromal crosstalk via a redox-responsive nanomedicine for combination tumor therapy","volume":"356","author":"Zhang","year":"2023","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115384_bb0075","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1021\/acsnano.3c10037","article-title":"Tumor-microenvironment-activatable nanoparticle mediating immunogene therapy and M2 macrophage-targeted inhibitor for synergistic cancer immunotherapy","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115384_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202208553","article-title":"Checkpoint Nano-PROTACs for activatable cancer photo-immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115384_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202000026","article-title":"Recent progress on activatable nanomedicines for immunometabolic combinational cancer therapy","volume":"1","author":"Zhang","year":"2020","journal-title":"Small Struct."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115384_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.789","article-title":"Immunometabolism: signaling pathways, homeostasis, and therapeutic targets","volume":"5","author":"Xu","year":"2024","journal-title":"Medcomm"},{"key":"10.1016\/j.jconrel.2026.115384_bb0095","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.2147\/IJN.S513207","article-title":"Reprogramming of glucose metabolism by nanocarriers to improve cancer immunotherapy: recent advances and applications","volume":"20","author":"Jiang","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115384_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202405845","article-title":"Tumor microenvironment-responsive nanoparticles enhance IDO1 blockade immunotherapy by remodeling metabolic immunosuppression","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115384_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007247","article-title":"Activatable polymer nanoenzymes for photodynamic immunometabolic cancer therapy","volume":"33","author":"Zeng","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115384_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1173356","article-title":"Methylthioadenosine phosphorylase deficiency in tumors: a compelling therapeutic target","volume":"11","author":"Fan","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"6278","key":"10.1016\/j.jconrel.2026.115384_bb0115","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1126\/science.aad5214","article-title":"MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells","volume":"351","author":"Kryukov","year":"2016","journal-title":"Science"},{"issue":"6278","key":"10.1016\/j.jconrel.2026.115384_bb0120","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aad5944","article-title":"Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5","volume":"351","author":"Mavrakis","year":"2016","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115384_bb0125","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.ccell.2023.09.005","article-title":"Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance","volume":"41","author":"Gjuka","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115384_bb0130","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.3389\/fimmu.2020.02128","article-title":"The oncometabolite 5\u2032-deoxy-5\u2032-methylthioadenosine blocks multiple signaling pathways of NK cell activation","volume":"11","author":"Jacobs","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115384_bb0135","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1038\/s41598-022-07697-0","article-title":"MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization","volume":"12","author":"Hansen","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115384_bb0140","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41467-022-29397-z","article-title":"MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers","volume":"13","author":"Alhalabi","year":"2022","journal-title":"Nat. Commun."},{"issue":"6769","key":"10.1016\/j.jconrel.2026.115384_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl4089","article-title":"MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists","volume":"390","author":"Hsu","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115384_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212804","article-title":"Matrix metalloproteinase-responsive collagen-oxidized hyaluronic acid injectable hydrogels for osteoarthritic therapy","volume":"137","author":"Yi","year":"2022","journal-title":"Biomater. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115384_bb0155","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1038\/s41467-022-31044-6","article-title":"Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115384_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202306336","article-title":"Chimeric exosomes functionalized with STING activation for personalized glioblastoma immunotherapy","volume":"11","author":"Bao","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115384_bb0165","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41467-021-23194-w","article-title":"Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"35","key":"10.1016\/j.jconrel.2026.115384_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202302728","article-title":"Metabolic regulation of tumor microenvironment with biohybrid bacterial bioreactor for enhanced cancer chemo-immunotherapy","volume":"33","author":"Han","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115384_bb0175","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies","volume":"5","author":"Vargason","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115384_bb0180","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115384_bb0185","article-title":"Mitochondrial metabolism and cancer therapeutic innovation","volume":"10","author":"Du","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"17","key":"10.1016\/j.jconrel.2026.115384_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202112251","article-title":"Tumor microenvironment activated chemodynamic-photodynamic therapy by multistage self-assembly engineered protein nanomedicine","volume":"32","author":"Zhang","year":"2022","journal-title":"Adv. Funct. Mater."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:45:38Z","timestamp":1793439938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926007881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S0168365926007881"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115384","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catalytical nanogels reprogram immunosuppressive metabolic networks for activatable cancer photo-immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115384"}}